Moshe Oren

Affiliations: 
MCB Molecular Cell Biology Weizmann Institute of Science, Rehovot, Israel 
Area:
Molecular Biology
Google:
"Moshe Oren"
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Shaked MS, Dassa B, Sinha S, et al. (2020) A division of labor between YAP and TAZ in non-small cell lung cancer. Cancer Research
Benor G, Fuks G, Chin SF, et al. (2020) Transcriptional profiling reveals a subset of human breast tumors that retain wt TP53 but display mutant p53-associated features. Molecular Oncology
Kotler E, Segal E, Oren M. (2018) Functional characterization of the p53 "mutome". Molecular & Cellular Oncology. 5: e1511207
Kotler E, Shani O, Goldfeld G, et al. (2018) A Systematic p53 Mutation Library Links Differential Functional Impact to Cancer Mutation Pattern and Evolutionary Conservation. Molecular Cell. 71: 873
Kotler E, Shani O, Goldfeld G, et al. (2018) A Systematic p53 Mutation Library Links Differential Functional Impact to Cancer Mutation Pattern and Evolutionary Conservation. Molecular Cell. 71: 178-190.e8
Shema E, Tirosh I, Aylon Y, et al. (2017) Corrigendum: The histone H2B-specific ubiquitin ligase RNF20/hBRE1 acts as a putative tumor suppressor through selective regulation of gene expression. Genes & Development. 31: 1926
Bublik DR, Bursać S, Sheffer M, et al. (2016) Regulatory module involving FGF13, miR-504, and p53 regulates ribosomal biogenesis and supports cancer cell survival. Proceedings of the National Academy of Sciences of the United States of America
Yaeger R, Shah MA, Miller VA, et al. (2016) Genomic Alterations Observed in Colitis-associated Cancers are Distinct from Those Found in Sporadic Colorectal Cancers and Vary by Type of Inflammatory Bowel Disease. Gastroenterology
Aylon Y, Gershoni A, Rotkopf R, et al. (2016) The LATS2 tumor suppressor inhibits SREBP and suppresses hepatic cholesterol accumulation. Genes & Development
Tal P, Eizenberger S, Cohen E, et al. (2016) Cancer therapeutic approach based on conformational stabilization of mutant p53 protein by small peptides. Oncotarget
See more...